Vor Biopharma Inc (VOR) Live Share Price, Invest From India

Vor Biopharma Inc Stock Performance

as on October 23, 2025 at 1:29 am IST

Day's Low
Day's High
$25.95
Day's Price Range
$27.45
$26.39
1.67%
Downside
4.02%
Upside
52 Week's Low
52 Week's High
$2.62
52-Week Price Range
$65.8
$26.39
90.06%
Downside
149.34%
Upside

Vor Biopharma Inc share price movements today

Previous Close: $27.77
Open: $27.01
Volume: 676.8K
Day's Low - High: $25.95 - $27.45
52 Week Low - High: $2.62 - $65.8

Vor Biopharma Inc Historical Returns

1 Month Return: -0.59 %
3 Month Return: -32.27 %
1 Year Return: + 95.34 %
3 Year Return: -66.3 %
5 Year Return: 0 %

Vor Biopharma Inc Stock Fundamentals & Key Indicators

Check Vor Biopharma Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$201.7M

EPS (TTM)

-173.745

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-332.1M

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

3311200.00%

Vor Biopharma Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Vor Biopharma Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Vor Biopharma Inc	BUY	$201.7M	NA	NA	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$64.4B	252.94%	-505.15	-12.96%
Beone Medicines Ltd	NA	$35.3B	NA	NA	-3.89%
Vertex Pharmaceuticals Incorporated	BUY	$107.5B	102.91%	29.68	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$61.3B	0.63%	14.58	31.37%

Stock Returns calculator for Vor Biopharma Inc Stock including INR - Dollar returns

The Vor Biopharma Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Vor Biopharma Inc investment value today

Current value as on today

₹1,90,141

Returns

₹90,141

(+90.14%)

Returns from Vor Biopharma Inc Stock

₹85,584 (+85.58%)

Dollar Returns*

₹4,557 (+4.56%)

Analyst Recommendation on Vor Biopharma Inc Stock

Based on 13 analysts

BUY

92.31%

Buy

7.69%

Hold

0.00%

Sell

Based on 13 analysts, 92.31% of analysts recommend a 'BUY' rating for Vor Biopharma Inc. Average target price of $46.75

Vor Biopharma Inc Share Price Target

Get share price movements and forecasts by analysts on Vor Biopharma Inc.

What analysts predicted

43.55%UPSIDE

Target Price

$46.75

Current Price

$26.39

Analyzed by

13 Analysts

Target

$46.75

Vor Biopharma Inc target price $46.75, a slight upside of 43.55% compared to current price of $26.39. According to 13 analysts rating.

Vor Biopharma Inc Stock’s Investor Sentiment and Interest

Search interest for Vor Biopharma Inc Stock has increased by 60% in the last 30 days, reflecting an upward trend in search activity.

Time period: September 23, 2025 to October 23, 2025

Change:60% versus previous 30 day period

Vor Biopharma Inc Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	-	-	-	12	-	-	-	3	-	-
Gross Profit	-2	-1	-2	11	0	0	0	1	0	-2
Operating Income	-30	-32	-35	-28	-32	-29	-28	-31	-33	-274
EBITDA	-29	-31	-34	-27	-31	-28	-27	-30	-33	-274
Interest Expense	1	-	-	1	-	-	-	-	-	-
Depreciation	0	3	-1	0	0	0	0	0	0	2
Income Before Tax	-28	-29	-33	-26	-30	-27	-27	-30	-32	-1,573
Income Tax Expense	-1	3	1	0	0	0	-	0	-	-
Net Income	-26	-29	-33	-26	-30	-27	-27	-30	-32	-1,573
Net Profit Margin	0.00%	0.00%	0.00%	-214.80%	0.00%	0.00%	0.00%	-833.21%	0.00%	0.00%

Vor Biopharma Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	-	-	-	-	-	-	-
Gross Profit	0	0	-1	-4	-8	-3	-3
Operating Income	-2	-10	-43	-69	-93	-126	-121
EBITDA	-2	-10	-41	-67	-90	-114	-113
Interest Expense	1	0	-	1	1	-	-
Depreciation	0	0	0	1	2	3	3
Income Before Tax	-4	-10	-43	-68	-92	-117	-116
Income Tax Expense	0	0	0	0	-1	-	-
Net Income	-4	-11	-43	-68	-90	-117	-116
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Vor Biopharma Inc Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-29	-33	-26	-30	-27	-27	-30	-32	-1,573
Operating Cash Flow	-24	-27	-24	-30	-21	-23	-24	-31	-35
Investing Cash Flow	13	40	10	43	52	0	0	0	0
Financing Cash Flow	0	0	0	0	0	0	53	0	175
Change in Cash	-38	12	-13	13	31	-23	29	-31	140

Vor Biopharma Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-10	-43	-68	-92	-117	-116
Operating Cash Flow	-9	-36	-69	-85	-100	-99
Investing Cash Flow	0	-4	-91	-94	71	96
Financing Cash Flow	17	82	232	117	2	53
Change in Cash	7	42	72	-62	-26	50

Global Institutional Holdings in Vor Biopharma Inc

Funds	Holdings
RA Capital Management, LLC	31.3%
5AM Venture Management, LLC	5.02%
FMR Inc	1.65%
Vanguard Group Inc	1.51%
UBS Group AG	1.21%

See all

Insights on Vor Biopharma Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Best in 1 Year
In the last 1 year, VOR has outperformed top 5 stocks with highest market-cap in its industry
NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 138.3% return, outperforming this stock by 204.6%
NEGATIVE IMPACT
Price Dip
In the last 3 months, VOR stock has moved down by -33.6%

About Vor Biopharma Inc

vor biopharma is pioneering engineered hematopoietic stem cells (ehscs) to dramatically change the treatment paradigm for hematological cancers. vor’s ehscs are designed to generate healthy, fully functional cells with specific advantageous modifications, for example to protect the blood and bone marrow from the toxic effects of antigen-targeted therapies, protecting healthy cells from depletion but leaving tumor cells vulnerable. vor’s platform could potentially be used to change the treatment paradigm of both hematopoietic stem cell transplants and antigen-targeted therapies such as antibody drug conjugates, bispecific antibodies and car-t cell treatments. a proof-of-concept study for vor’s lead program has been published in proceedings of the national academy of sciences. vor is based in cambridge, mass. and has a broad intellectual property base including in-licenses from columbia university, where foundational work was conducted by inventor and vor scientific board chair siddhar

Organisation	Vor Biopharma Inc
Headquarters	100 Cambridgepark Drive, Cambridge, MA, United States, 02140
Industry	Services
CEO	Dr. Jean-Paul Kress M.D.
E-voting on shares	Click here to vote

Key Management of Vor Biopharma Inc

Name	Title
Ms. Tania Philipp	Chief People Officer
Dr. Navid Z. Khan	Chief Medical Affairs Officer
Dr. Jean-Paul Kress M.D.	Chairman & CEO
Ms. Adi Osovsky	General Counsel
Mr. Sandesh Mahatme L.L.M.	Chief Business Officer & CFO
Dr. Qing Zuraw M.B.A., M.D., M.P.H.	Chief Development Officer
Mr. Dallan Murray	Chief Commercial Officer
Dr. Robert Ang M.B.A., M.D., MBBS	Strategic Advisor
Dr. Siddhartha Mukherjee DPHIL, M.D., Ph.D.	Scientific Founder & Chairman of Scientific Advisory Board

FAQs

What is Vor Biopharma Inc share price today?

Vor Biopharma Inc share price today is $26.39 as on October 23, 2025 at 1:29 am IST at the close of the market. Vor Biopharma Inc share today touched a day high of $27.45 and a low of $25.95.

What is the 52 week high and 52 week low for Vor Biopharma Inc share?

Vor Biopharma Inc share touched a 52 week high of $65.8 on July 8, 2025 and a 52 week low of $2.62 on May 9, 2025. Vor Biopharma Inc stock price today i.e. October 23, 2025 at 1:29 am IST is closed at $26.39,which is 59.89% down from its 52 week high and 906.48% up from its 52 week low.

What is Vor Biopharma Inc's market capitalisation today?

Vor Biopharma Inc market capitalisation is $0.00T as on October 23, 2025 at 1:29 am IST.

How to invest in Vor Biopharma Inc Stock (VOR) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Vor Biopharma Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Vor Biopharma Inc Shares that will get you 0.0568 shares as per Vor Biopharma Inc share price of $26.39 per share as on October 23, 2025 at 1:29 am IST.

What is the minimum amount required to buy Vor Biopharma Inc Stock (VOR) from India?

Indian investors can start investing in Vor Biopharma Inc (VOR) shares with as little as ₹87.755 or $1 (as of October 23, 2025 at 10:42 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹877.55 in Vor Biopharma Inc stock (as per the Rupee-Dollar exchange rate as on October 23, 2025 at 10:42 am IST). Based on Vor Biopharma Inc share’s latest price of $26.39 as on October 23, 2025 at 1:29 am IST, you will get 0.3789 shares of Vor Biopharma Inc. Learn more about fractional shares .